glp 1 blindness study GLP-1 Receptor Agonists and vision risk The Impact of GLP-1 Receptor
Description
GLP-1 receptor activation induces vasodilation through various pathways
Furthermore, the two groups had no evidence of a difference in mortality rate (HR 1.06
GLP-1 agonists may cause nausea, vomiting, diarrhea, GI issues, and an increased risk of infections
Retatrutide was associated with a greater increase in resting heart rate than tirzepatide in clinical trials
The Cleveland Clinic analysis found that many patients who stopped GLP-1 therapy later restarted, sometimes with the same medication, sometimes switching to an alternative
[DOI] [PubMed] [Google Scholar] 48.Vonlaufen A, Wilson JS, Apte MV
